| Identification | Back Directory | [Name]
4-Amino-1-[[(carbamoylamino)acetyl]methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol | [CAS]
62874-51-5 | [Synonyms]
Fortimicin C
4-Amino-1-[[(carbamoylamino)acetyl]methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol
L-chiro-Inositol, 4-amino-1-[[2-[(aminocarbonyl)amino]acetyl]methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl- | [Molecular Formula]
C18H36N6O7 | [MOL File]
62874-51-5.mol | [Molecular Weight]
448.51 |
| Hazard Information | Back Directory | [Uses]
Fortimicin C is an antibiotic, which can be isolated from Micromonospora olivoasterospora. Fortimicin C exhibits broad-spectrum antibacterial activity, inhibits Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Salmonella typhosa and Serratia marcescens, with MICs of 0.16-0.64 μg/mL. Fortimicin C is resistant against aminoglycoside inactivating enzymes[1]. | [IC 50]
Aminoglycoside | [References]
[1] Sugimoto M, et al., Fortimicins C, D and KE, new aminoglycoside antibiotics. J Antibiot (Tokyo). 1979 Sep;32(9):868-73. DOI:10.7164/antibiotics.32.868 |
|
|